Study of Sildenafil in Patient With Heart Failure.
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00309816|
Recruitment Status : Completed
First Posted : April 3, 2006
Last Update Posted : April 3, 2006
|Condition or disease||Intervention/treatment||Phase|
|Congestive Heart Failure||Drug: sildenafil||Phase 3|
|Study Type :||Interventional (Clinical Trial)|
|Estimated Enrollment :||40 participants|
|Intervention Model:||Single Group Assignment|
|Masking:||None (Open Label)|
|Official Title:||Measurement of the Effect of Sildenafil Citrate (Viagra) on the Hemodynamics of Exercise Tolerance in Advanced Congestive Heart Failure.|
|Study Start Date :||December 2001|
|Estimated Study Completion Date :||February 2006|
- Patients will have exercise capacity measured by an exercise stress test before and after one dose of sildenafil.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00309816
|United States, Massachusetts|
|Massachusetts General Hospital|
|Boston, Massachusetts, United States, 02114|
|Principal Investigator:||Marc J Semigran, MD||Massachusetts General Hospital|